Prevention & lipidsRandomised controlled trial
Primary Prevention of Subclinical Atherosclerosis in Young Adults
- Randomised controlled trial (design and rationale)
Study context
- Population
- Healthy adults aged 20 to 39 years without known cardiovascular disease (CVD)
- Comparison
- Aggressive CV risk factor control vs not stated
- Primary endpoint
- Change in total atherosclerosis burden (surrogate for CVD)
Original publication
Primary Prevention of Subclinical Atherosclerosis in Young Adults. J Am Coll Cardiol. Published 28 November 2023. doi:10.1016/j.jacc.2023.09.817
Summarised from the published abstract; every number is checked against it